Anurag Patankar
About Anurag Patankar
Anurag Patankar is a Clinical Implementation Specialist with extensive experience in clinical data management and operations. He has worked with notable companies such as Cognizant and Novartis, and currently specializes in implementing eConsent and ePRO systems at Castor in Amsterdam.
Current Role at Castor
Anurag Patankar currently serves as a Clinical Implementation Specialist at Castor, a position he has held since 2022 in Amsterdam, North Holland, Netherlands. In this role, he focuses on implementing electronic consent (eConsent) and electronic patient-reported outcomes (ePRO) systems, which are vital for the efficiency and accuracy of modern clinical trials.
Previous Experience at Cognizant
Anurag Patankar has extensive experience at Cognizant, where he held multiple roles. He worked as an Onsite Coordinator for Clinical Data Management in Lyon Area, France, from 2018 to 2019. He then served as Team Lead and Lead Data Manager from 2019 to 2021 in Mumbai, Maharashtra, India. Additionally, he was a Clinical Data Analyst at Cognizant from 2013 to 2018 in Powai, Mumbai.
Experience at Novartis
Anurag Patankar worked at Novartis as a Principal Clinical Data Manager for a period of four months in 2021 to 2022. This role contributed to his expertise in managing clinical data and ensuring compliance with industry standards.
Education and Expertise
Anurag Patankar studied at Mumbai University, where he earned a Master of Science (MSc) in Biotechnology from 2010 to 2012. He also obtained a Bachelor of Science (BSc) in Biotechnology from the same university from 2007 to 2010. His educational background supports his proficiency in clinical data management and operations management.
Skills and Competencies
Anurag Patankar possesses a range of skills relevant to the clinical research field. He is proficient in conducting User Acceptance Testing to ensure clinical trial systems meet user requirements. His expertise includes managing client relationships, overseeing operations, and leading teams, which highlights his capability to enhance clinical trial processes and workflows.